Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
Hamee
3134
River Eletec
6666
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 94.77%13.6B | -41.48%6.98B | -30.59%11.93B | 8.37%17.19B | 45.06%15.86B | 37.60%10.93B | -36.08%7.95B | -5.31%12.43B | -27.73%13.13B | 53.62%18.16B |
Net profit before non-cash adjustment | 49.12%12.22B | -13.01%8.19B | -25.43%9.42B | 5.69%12.63B | 80.58%11.95B | 19.10%6.62B | -22.40%5.56B | -35.66%7.16B | -9.69%11.13B | 7.12%12.32B |
Total adjustment of non-cash items | -19.52%4.42B | 14.58%5.49B | 10.51%4.79B | -3.66%4.34B | -8.64%4.5B | 0.67%4.93B | 68.31%4.9B | 7.38%2.91B | -40.62%2.71B | 54.91%4.56B |
-Depreciation and amortization | 11.98%5.07B | -5.16%4.52B | 1.15%4.77B | -0.74%4.72B | 7.05%4.75B | -28.75%4.44B | 66.42%6.23B | 12.20%3.74B | 2.33%3.34B | -0.09%3.26B |
-Reversal of impairment losses recognized in profit and loss | --0 | 113.07%603M | --283M | --0 | ---- | ---- | ---162M | ---- | ---- | --1.56B |
-Disposal profit | -115.64%-28M | 1,591.67%179M | -138.71%-12M | -65.56%31M | 141.67%90M | 84.73%-216M | -106.27%-1.42B | -264.89%-686M | -241.35%-188M | 256.47%133M |
-Other non-cash items | -429.95%-617M | 175.71%187M | 39.61%-247M | -21.01%-409M | -147.81%-338M | 189.75%707M | 264.86%244M | 66.29%-148M | -13.14%-439M | -66.52%-388M |
Changes in working capital | 54.66%-3.04B | -193.96%-6.71B | -1,147.25%-2.28B | 136.70%218M | 3.41%-594M | 75.48%-615M | -206.23%-2.51B | 432.07%2.36B | -155.68%-711M | 148.63%1.28B |
-Change in receivables | 3.15%-3.32B | -391.09%-3.43B | 41.71%1.18B | 137.18%832M | -114.37%-2.24B | 58.41%-1.04B | -226.64%-2.51B | 118.28%1.98B | 257.64%908M | 69.70%-576M |
-Change in inventory | 80.73%-906M | -47.51%-4.7B | -998.97%-3.19B | -61.11%-290M | 77.78%-180M | -135.47%-810M | -148.73%-344M | 214.42%706M | -199.52%-617M | 187.82%620M |
-Change in payables | -78.75%292M | 1,149.09%1.37B | 186.61%110M | -111.22%-127M | 31.17%1.13B | 314.90%863M | 817.24%208M | 97.69%-29M | -202.04%-1.25B | 443.98%1.23B |
-Provision for loans, leases and other losses | 539.04%933M | 152.90%146M | -55.93%-276M | -125.00%-177M | 148.42%708M | 7,025.00%285M | 101.18%4M | -372.22%-340M | -278.95%-72M | -113.01%-19M |
-Changes in other current assets | 61.22%-38M | 10.09%-98M | -445.00%-109M | -25.00%-20M | -117.58%-16M | -32.09%91M | 219.05%134M | -87.00%42M | 1,245.83%323M | -87.50%24M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -260.00%-54M | -87.50%-15M | 68.00%-8M | 59.68%-25M | -47.62%-62M | -23.53%-42M | 26.09%-34M | -1,050.00%-46M | 20.00%-4M | 0.00%-5M |
Interest received (cash flow from operating activities) | 94.67%292M | 15.38%150M | -7.80%130M | -43.15%141M | 8.77%248M | 72.73%228M | 43.48%132M | -13.21%92M | 7.07%106M | 1.02%99M |
Tax refund paid | 55.05%-1.51B | 12.74%-3.36B | 23.66%-3.86B | -48.79%-5.05B | -10.52%-3.39B | -115.36%-3.07B | 46.95%-1.43B | 46.08%-2.69B | -15.50%-4.99B | -7.68%-4.32B |
Other operating cash inflow (outflow) | 0 | 0 | 27,700.00%276M | 0.00%-1M | 0.00%-1M | 0.00%-1M | -1M | 0 | 0.00%-1M | -1M |
Operating cash flow | 228.47%12.32B | -55.72%3.75B | -30.85%8.47B | -3.15%12.25B | 57.21%12.65B | 21.61%8.05B | -32.40%6.62B | 18.75%9.79B | -40.87%8.24B | 76.26%13.94B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | 53.39%-1.33B | 50.40%-2.86B | -175.68%-5.77B | 36.71%-2.09B | -3.44%-3.31B |
Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.91B | ---- | ---- |
Net business purchase and sale | -47.20%-368M | ---250M | --0 | ---- | 93.33%-845M | -1,950.97%-12.68B | -1,304.55%-618M | 98.21%-44M | 5.02%-2.46B | ---2.59B |
Net investment product transactions | 112.64%197M | -418.81%-1.56B | -31.42%489M | -94.27%713M | 970.91%12.44B | -26.92%1.16B | 988.27%1.59B | -110.18%-179M | 719.01%1.76B | -220.34%-284M |
Net changes in other investments | -17.93%-14.26B | -121.63%-12.09B | -19.37%-5.46B | 31.58%-4.57B | -1,348.81%-6.68B | -5,862.50%-461M | 103.15%8M | -225.64%-254M | 19.59%-78M | 65.60%-97M |
Investing cash flow | -3.81%-14.43B | -179.88%-13.9B | -28.75%-4.97B | -178.39%-3.86B | 136.97%4.92B | -607.12%-13.31B | 56.60%-1.88B | -50.87%-4.34B | 54.23%-2.87B | -93.62%-6.28B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 105.10%11.95B | 290.36%5.83B | -91.61%-3.06B | 89.14%-1.6B | -183.01%-14.7B | 11,868.24%17.71B | -12.43%148M | --169M | ---- | ---- |
Net common stock issuance | ---2M | --0 | ---4.08B | --0 | -934,100.00%-9.34B | ---1M | --0 | -101.49%-1M | -41.74%67M | -53.25%115M |
Cash dividends paid | -14.30%-4.9B | -49.22%-4.29B | -29.01%-2.87B | -22.16%-2.23B | -12.53%-1.82B | 11.09%-1.62B | 4.26%-1.82B | 25.28%-1.9B | -5.47%-2.55B | -31.18%-2.42B |
Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---49M |
Net other fund-raising expenses | -30.34%-116M | -1,171.43%-89M | 87.50%-7M | 94.70%-56M | -2,302.27%-1.06B | -4.76%-44M | -16.67%-42M | 10.00%-36M | -8.11%-40M | 2.63%-37M |
Financing cash flow | 378.19%6.93B | 114.46%1.45B | -158.30%-10.02B | 85.59%-3.88B | -267.78%-26.93B | 1,035.20%16.05B | 3.11%-1.72B | 29.72%-1.77B | -5.62%-2.52B | -37.68%-2.39B |
Net cash flow | ||||||||||
Beginning cash position | -29.03%20.1B | -17.44%28.32B | 15.80%34.3B | -23.92%29.62B | 37.66%38.93B | 12.51%28.28B | 16.35%25.14B | 14.69%21.61B | 38.66%18.84B | 38.17%13.59B |
Current changes in cash | 155.42%4.82B | -33.48%-8.7B | -244.41%-6.52B | 148.24%4.51B | -186.74%-9.36B | 257.39%10.79B | -17.99%3.02B | 29.21%3.68B | -46.00%2.85B | 79.88%5.27B |
Effect of exchange rate changes | 3.14%492M | -10.84%477M | 218.45%535M | 411.11%168M | 60.00%-54M | -262.65%-135M | 156.46%83M | -41.35%-147M | -447.37%-104M | -123.75%-19M |
Cash adjustments other than cash changes | ---- | --1M | ---- | ---- | --96M | ---- | 4,500.00%44M | -104.35%-1M | 1,250.00%23M | -100.27%-2M |
End cash Position | 26.44%25.41B | -29.03%20.1B | -17.44%28.32B | 15.80%34.3B | -23.92%29.62B | 37.66%38.93B | 12.51%28.28B | 16.35%25.14B | 14.69%21.61B | 38.66%18.84B |
Free cash flow | 228.47%12.32B | -55.72%3.75B | -30.85%8.47B | -3.15%12.25B | 116.52%12.65B | 56.08%5.84B | 1.91%3.74B | -38.94%3.67B | -43.31%6.02B | 129.41%10.61B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |